期刊文献+

新型二硫化钼荧光传感器检测乳腺癌相关miRNA 被引量:1

MoS_2-based fluorescence sensor for the detection of breast cancer-related microRNA
下载PDF
导出
摘要 目的建立一种快速简便、高敏感性、高特异性的基于新型纳米材料二硫化钼的荧光传感器用于乳腺癌相关微小RNA(miRNA)检测的方法。方法在荧光标记的DNA探针体系中加入新型纳米材料二硫化钼构建一种荧光传感器,然后在荧光传感器中分别加入非互补miRNA、单碱基错配的miRNA、不同浓度的互补miRNA与荧光标记的DNA探针进行杂交,通过检测杂交前后荧光信号的变化来检测miRNA。结果检测只需40 min即可完成,对互补miRNA的检出限可达pmol/L级,且能够将互补、非互补、单碱基错配的miRNA区分开来。结论该新型的纳米材料二硫化钼荧光传感器分析速度快、敏感性和特异性高,建立的检测方法可应用于乳腺癌相关miRNA的快速检测,是一种非常有潜力的检测方法。 Objective To establish a fast,convenient,sensitive and specific fluorescence sensor based on novel nanomaterial MoS2 to detect breast cancer-related microRNA(miRNA). Methodse The fluorescence sensor was fabricated by mixing novel nanomaterial MoS2 with fluorescent dye-labeled DNA probe. Noncomplementary miRNA,one-base mismatched miRNA and different concentrations of complementary miRNA were introduced to fluorescence sensor for hybridization with DNA probe. The miRNA was detected through monitoring fluorescence signal change before and after DNA probe-miRNA hybridization. Results The pmol/L level of complementary miRNA could be detected within 40 min,and fluorescence sensor could discriminate complementary miRNA from noncomplementary miRNA and one-base mismatched miRNA. Conclusions The novel nanomaterial MoS2-based fluorescence sensor has the advantages of fast,high sensitivity and specificity,and it is potential for the detection of breast cancer-related miRNA.
出处 《检验医学》 CAS 2017年第5期427-430,共4页 Laboratory Medicine
基金 国家自然科学基金项目(21475034)
关键词 二硫化钼 荧光传感器 乳腺癌 微小RNA MoS2 Fluorescence sensor Breast cancer MicroRNA
  • 相关文献

参考文献4

二级参考文献51

  • 1管海涛,薛锋杰,王西京,薛兴欢,刘小旭,代志军,闵卫利,宋玲琴.乳腺癌中survivin表达的预后价值[J].现代肿瘤医学,2007,15(7):938-940. 被引量:6
  • 2Nasu S,Yagihashi A,Izawa A,et al.Survivin mRNA expression in patients with breast cancer[J].Anticancer Res,2002,22(3):1839-1843.
  • 3Izawa A,Kobayashi D,Nasu S,et al.Relevance of c-erbB2,PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer[J].Anticancer Res,2002,22(5):2965-2969.
  • 4Jinga DC,Blidaru A,Condrea I,et al.MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer:correlations with prognostic factors[J].J Cell Mol Med,2006,10(2):499-510.
  • 5Wu WT,Chen CN,Lin CI,et al.Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells[J].Endocrinology,2005,146(8):3387-3400.
  • 6Ho SB,Hyslop A,Albrecht R,et al.Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen[J].Clin Cancer Res,2004,10(17):5777-5784.
  • 7Kumazawa Y,Kawamura K,Sato T,et al.HCG up-regulates survivin mRNA in human granulosa cells[J].Mol Hum Reprod,2005,11(3):161-166.
  • 8Janku F,Srovnal J,Korinkova G,et al.Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA[J].Neoplasma,2008,55(4):317-322.
  • 9An XY,Egami H,Hayashi N,et al.Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer[J].Tohoku J Exp Med,2001,193(2):153-162.
  • 10Baker EA,Stephenson TJ,Reed MW,et al.Expression of proteinases and inhibitors in human breast cancer progression and survival[J].Mol Pathol,2002,55(5):300-304.

共引文献167

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部